Influence of cytochrome P450 2D6*10/*10 genotype on the risk for tramadol associated adverse effects: a retrospective cohort study.

MLA

Mahajna, Mahmood, et al. “Influence of Cytochrome P450 2D6*10/*10 Genotype on the Risk for Tramadol Associated Adverse Effects: A Retrospective Cohort Study.” Frontiers in Pharmacology, vol. 15, Feb. 2024, p. 1358549. EBSCOhost, https://doi.org/10.3389/fphar.2024.1358549.

APA

Mahajna, M., Abu Fanne, R., Odeh, M., Berkovitch, M., Tannous, E., Eyal, S., Vinker, S., Green, I., & Matok, I. (2024). Influence of cytochrome P450 2D6*10/*10 genotype on the risk for tramadol associated adverse effects: a retrospective cohort study. Frontiers in Pharmacology, 15, 1358549. https://doi.org/10.3389/fphar.2024.1358549

Chicago

Mahajna, Mahmood, Rami Abu Fanne, Mahmoud Odeh, Matitiahu Berkovitch, Elias Tannous, Sara Eyal, Shlomo Vinker, Ilan Green, and Ilan Matok. 2024. “Influence of Cytochrome P450 2D6*10/*10 Genotype on the Risk for Tramadol Associated Adverse Effects: A Retrospective Cohort Study.” Frontiers in Pharmacology 15 (February): 1358549. doi:10.3389/fphar.2024.1358549.